dr now glp 1 For years, you've asked me for help. Now, for the first time, I'm laun Lost Too Much Weight On

The worlds fastest growing drugs are already facing Loss of Exclusivity in 2026 Semaglutide is the active ingredient in both Ozempic, an injectable agent for diabetes, as well as Wegovy, an injectable for obesity treatment

These medications mimic a hormone called GLP-1, which helps to regulate appetite and blood sugar

But from a neuropathology perspective, the evidence is thin

Today, we announced our investigational glucagon/GLP-1 dual receptor agonist achieved key measures of success at 48 weeks in our IMPACT Phase 2b trial and recent interactions with the FDA have resulted in alignment on the parameters for a registrational Phase 3 trial